| Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
| F16IL2 | Antibody | none | Tenascin other | 2 | ['Terminated', 'Terminated', 'Completed', 'Active, not recruiting', 'Active, not recruiting'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| TENATUMOMAB | Antibody | none | Tenascin other | 1 | ['Terminated', 'Terminated', 'Terminated', 'Terminated', 'Terminated', 'Terminated', 'Terminated', 'Terminated'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| 81C6 131I | Antibody | none | Tenascin binding agent | 1 | ['Completed', 'Completed', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| F16SIP 131I | Antibody | none | Tenascin binding agent | 1 | ['Completed'] | ['ClinicalTrials'] |